Evidence map›Paper›PMID 35745020›Full record

ReviewMolecules (Basel, Switzerland)2022

Palladium-Catalyzed Organic Reactions Involving Hypervalent Iodine Reagents.

Samata E Shetgaonkar, Ritu Mamgain, Kotaro Kikushima, Toshifumi Dohi, Fateh V Singh

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Iodine(V)-Based Oxidants in Oxidation Reactions.Molecules (Basel, Switzerland) · 2023
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samata E ShetgaonkarChemistry Division, School of Advanced Sciences (SAS), Vellore Institute of Technoloy-Chennai, Chennai 600127, Tamil Nadu, India.
Ritu MamgainChemistry Division, School of Advanced Sciences (SAS), Vellore Institute of Technoloy-Chennai, Chennai 600127, Tamil Nadu, India.
Kotaro KikushimaCollege of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu 525-0058, Shiga, Japan.
Toshifumi DohiCollege of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu 525-0058, Shiga, Japan.ORCID 0000-0002-2812-9581
Fateh V SinghChemistry Division, School of Advanced Sciences (SAS), Vellore Institute of Technoloy-Chennai, Chennai 600127, Tamil Nadu, India.ORCID 0000-0002-6358-4408

Funding

JSPS KAKENHI 19K05466
6 · The paper itself

Abstract

The chemistry of polyvalent iodine compounds has piqued the interest of researchers due to their role as important and flexible reagents in synthetic organic chemistry, resulting in a broad variety of useful organic molecules. These chemicals have potential uses in various functionalization procedures due to their non-toxic and environmentally friendly properties. As they are also strong electrophiles and potent oxidizing agents, the use of hypervalent iodine reagents in palladium-catalyzed transformations has received a lot of attention in recent years. Extensive research has been conducted on the subject of C-H bond functionalization by Pd catalysis with hypervalent iodine reagents as oxidants. Furthermore, the iodine(III) reagent is now often used as an arylating agent in Pd-catalyzed C-H arylation or Heck-type cross-coupling processes. In this article, the recent advances in palladium-catalyzed oxidative cross-coupling reactions employing hypervalent iodine reagents are reviewed in detail.

Indexed as

IodinePalladiumCatalysisIndicators and ReagentsIodidesOxidantsOxidation-ReductionIndicators and ReagentsIodidesIodineOxidantsPalladiumbond formationcatalysthypervalent iodine reagentsoxidantpalladium

Identifiers

PMID35745020
PMCPMC9230104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.